A. Abraham

1.1k citations
32 papers · 817 indexed · h-index 16

A. Abraham

31 papers receiving 799 citations

Peers

A. Abraham
Comparison fields: 5 of 90
  • Nephrology 269
  • Virology 150
  • Infectious Diseases 210
  • Emergency Medicine 109
  • Hepatology 51
Replace R. García with:
R. García Spain
Alicja Wiercińska‐Drapało Poland
Carl Johan Treutiger Sweden
Leslie Obert United States
Andreas Weimann Germany
M. Henry France
Stephen H. Norris United States
Isabel Ojanguren Spain
Mélanie R. Tardif Canada
Morio Sawamura Japan
A. Abraham relative to R. García Spain R. García's profile →
Citations per field
00.5×7.3×
R. García · 1×
Citations per year

Countries citing papers authored by A. Abraham

Since Specialization
Citations

This map shows the geographic impact of A. Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Abraham more than expected).

Fields of papers citing papers by A. Abraham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Abraham. The network helps show where A. Abraham may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A. Abraham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Abraham Line = papers co-authored together A. Abraham links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202013
2 201827
3 201512
4 200069
5 199751
6 199727
7
Polyglutamylation of the dihydrofolate reductase inhibitor gamma-methylene-10-deazaaminopterin is not essential for antitumor activity.
19962
8 199550
9 19959
10 199427
11 199428
12 199449
13 199341
14 199392
15 1992103
16 198919
17 198726
18 19861
19 19852
20 198415

About A. Abraham

A. Abraham is a scholar working on Nephrology, Biochemistry and Virology, having authored 32 papers that have together received 817 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (9 papers), Amino Acid Enzymes and Metabolism (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Pharmacogenetics and Drug Metabolism (2 papers), Diet and metabolism studies (2 papers), Melanoma and MAPK Pathways (2 papers), Cutaneous Melanoma Detection and Management (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Nephrology (269 citations), Virology (150 citations) and Infectious Diseases (210 citations). A. Abraham has collaborated with scholars based in United States, Kuwait and China. Frequent co-authors include Paul L. Kimmel, Tünde Farkas-Szallasi, Carleton T. Garrett, István Bódi, Zsolt B. Argényi, Terry M. Phillips, Anh V. Nguyen, Christine Bromley, B. Shohat and S. Gitter. Their work appears in journals such as American Journal of Kidney Diseases, American Journal of Dermatopathology, Kidney International, American Journal of Clinical Pathology and Mycopathologia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026